Author: Jenny Lu

Absences from work of employed full-time wage and salary workers by occupation and industry. (2018). Available at: https://www.bls.gov/cps/cpsaat47.htm#cps_eeann_abs_ft_occu_ind.f.1. (Accessed: 17th September 2018) Rebecca J. Mitchell, P. B. Measuring Health-Related Productivity Loss. Popul. Health Manag. 14, 93 (2011). Finch, R. & Phillips,…

We are delighted to be included in the 2017 selections for the Digital Health Emerging Rockets. This list profiles British Columbia technology companies that will lead market breakthroughs by providing tools and services to facilitate better health. After a successful 2016,…

The opioid crisis is gripping communities across Canada and public health officials are imploring for innovative solutions and more research on drug addiction. The clinical management of pain continues to be challenging for patients and health care providers, in part because…

Welcome to the GenXys newsletter! We will keep you informed about the latest research, news, and events. In our latest issue: A behind the scenes look into GenXys Latest Research:*News release from The University of British Columbia (UBC) about our latest…

Click here to view our video A behind the scenes look into TreatGx What makes TreatGx unique? Unlike other pharmacogenetic software, TreatGx helps patients and healthcare professionals identify which medications will be safe and effective for the treatment of conditions commonly…

Every one of us responds to medications in different ways as we have a unique genetic code, distinct lifestyles and unique environmental factors surrounding us. Because of this, the type and severity of side effects for the same medication and same…

We presented two posters about our work on collection methods and whole genome amplification for pharmacogenetics as well as on the implementation of pharmacogenetics with clinical decision support in primary care. Also, we had great conversations with attendees that stopped by…

Attending the ASHG 2016 in Vancouver? Swing by our booth (#1128) to meet the GenXys team and learn more about our personalized medicine approach. Here are three great reasons you’ll want to visit us: Opportunity to win a FREE myPGx, pharmacogenetic…

The expectation that government decision-making be built on a foundation of credible evidence has become a growing demand of the Canadian public and the health care system. Access to information, availability of appropriate resources, and strong relationships with researchers are just…

Vancouver, August 30, 2018. GenXys, a precision prescribing software company tackling a $130 billion global problem, is pleased to announce that it has secured $1.5 million in seed funding following early commercial success in Canada. This supports GenXys plans to expand…